Evidence map›Paper›PMID 30072395›Full record

ArticleCancer research2018

A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma.

Stefania Oliveto, Roberta Alfieri, Annarita Miluzio, Alessandra Scagliola, Raissa S Secli, Pierluigi Gasparini, Stefano Grosso, Luciano Cascione, Luciano Mutti, Stefano Biffo

Abstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tight junctions and their regulation by non-coding RNAs.International journal of biological sciences · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Stefania OlivetoINGM, National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milano, Italy.
Roberta AlfieriINGM, National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milano, Italy.
Annarita MiluzioINGM, National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milano, Italy.
Alessandra ScagliolaINGM, National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milano, Italy.
Raissa S SecliDBS, University of Milan, Milan, Italy.
Pierluigi GaspariniDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio.
Stefano GrossoMRC Toxicology Unit, University of Leicester, Leicester, United Kingdom.
Luciano CascioneBioinformatics Core Unit, Institute of Oncology Research, Bellinzona, Switzerland.ORCID 0002-4606-0637
Luciano MuttiSbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, Pennsylvania.
Stefano BiffoINGM, National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milano, Italy. biffo@ingm.org.
University of Milan · ITIstituto Nazionale Genetica Molecolare · ITInstitute of Oncology Research · CHTemple University · USThe Ohio State University · USUniversity of Leicester · GB

Funding

European Research Council 338999
6 · The paper itself

Abstract

The expression of miRNAs in cancer has been widely studied and has allowed the definition of oncomirs and oncosuppressors. We note that it is often underestimated that many mRNAs are expressed, but translationally silent. In spite of this, systematic identification of miRNAs in equilibrium with their target mRNAs on polysomes has not been widely exploited. To identify biologically active oncomirs, we performed a screen for miRNAs acting on the polysomes of malignant mesothelioma (MPM) cells. Only a small percentage of expressed miRNAs physically associated with polysomes. On polysomes, we identified miRNAs already characterized in MPM, as well as novel ones like miR-24-3p, which acted as a promigratory miRNA in all cancer cells tested. miR-24-3p positively regulated Rho-GTP activity, and inhibition of miR-24-3p reduced growth in MPM cells. Analysis of miR-24-3p common targets, in two mesothelioma cell lines, identified a common subset of downregulated genes. These same genes were downregulated during the progression of multiple cancer types. Among the specific targets of miR-24-3p was cingulin, a tight junction protein that inhibits Rho-GTP activity. Overexpression of miR-24-3p only partially abrogated cingulin mRNA, but completely abrogated cingulin protein, confirming its action via translational repression. We suggest that miR-24-3p is an oncomir and speculate that identification of polysome-associated miRNAs efficiently sorts out biologically active miRNAs from inactive ones.

Indexed as

AnimalsCell Line, TumorCell MovementDisease ProgressionGene Expression ProfilingHumansLung NeoplasmsMembrane ProteinsMesotheliomaMesothelioma, MalignantMiceMice, Inbred NODMice, SCIDMicrofilament ProteinsMicroRNAsNeoplasm MetastasisCGN protein, humanMembrane ProteinsMicrofilament ProteinsMicroRNAsMIRN24 microRNA, human

Identifiers

PMID30072395
PMCPMC6193539
OpenAlexW2887309023

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.